Table 1.
Chemokine serum levels in patients with chronic idiopathic urticaria (CIU)
| Patients | CXCL10 | CXCL9 | CXCL8 | CCL2 | CCL5 |
|---|---|---|---|---|---|
| (n) | pg/ml | pg/ml | pg/ml | pg/ml | ng/ml |
| ASST+ (21) | 1747 ± 252·1 | 1933 ± 366·7 | 35·4 ± 5·0 | 433·6 ± 87·1 | 84·3 ± 15·1 |
| ASST- (17) | 1487 ± 194·7 | 1639 ± 217·4 | 72·5 ± 18·8 | 425·6 ± 66·8 | 84·3 ± 10·2 |
| BHR+ (10) | 1294 ± 134·8 | 1936 ± 469·0 | 54·1 ± 23·5 | 414·6 ± 144·3 | 85·3 ± 19·0 |
| BHR- (24) | 1618 ± 181·5 | 1700 ± 242·0 | 57·2 ± 12·6 | 507·1 ± 63·2 | 86·7 ± 8·6 |
| ANG+ (16) | 1403 ± 159 | 1424 ± 271·9 | 42·29 ± 5·26 | 474·0 ± 97·5 | 82·0 ± 10·5 |
| ANG- (11) | 1343 ± 155 | 1387 ± 197·9 | 64·83 ± 21·39 | 351·0 ± 58·0 | 85·4 ± 23·7 |
Autologous serum skin test (ASST) or basophil histamine release assay (BHR) in 38 patients with CIU expressed as mean ± standard error of the mean. Association with angioedema (ANG+).